Turnstone Biologics chooses R&D Time for Project Time Collection and FTE reporting.
December 2019 — With offices in Ottawa and New York City, Turnstone Biologics' mission is to deliver breakthrough viral immunotherapies to improve survival for patients with cancer.
Turning Point Therapeutics has selected R&D Logic as the corporate and portfolio FP&A solution.
June 2019 — Located in San Diego, CA, Turning Point Therapeutics has created a new generation of therapies that are different from the conventional kinase inhibitors. Their compact molecules are potentially more potent and selective medicines that also hold promise to prevent and overcome resistance.
Join us at the Westin Copley Place in Boston, MA, May 28-31, 2019.
May 2019 — R&D Logic Panel: Thursday, May 30th, at 2:15. R&D Logic Panel Discussion Topic: "Financial and Resource Management - TARGETED Reporting and Dashboards – why it matters". Review the agenda and register here.
We appreciate Casebia Therapeutics for selecting R&D Logic's R&D Time for project time collection.
March 2019 — Located in Cambridge, MA, Casebia combines CRISPR/Cas9 expertise and technology from CRISPR Therapeutics with access to deep disease-state knowledge and protein engineering capabilities from Bayer.